Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets.

Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie. Medicinal product subject to medical prescription.

Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.

PA 126/356/1-3. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: July 2023. 2023/ADV/RAN/154H.

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

BOOTS IRELAND LAUNCHES NEW LIVER SCANNING SERVICE

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

The NMH Foundation Announces Sponsorship with Bepanthen Nappy Care Ointment on World Prematurity Day

56% of Irish parents state that their children missed schools days in the past year due to flu or flu-like conditions with 1 in 5 relying on grandparents to mind children while ill

TWO OUT OF THREE PEOPLE IN IRELAND FEEL STRESSED AT LEAST ONCE A WEEK

RECOMMENDED NEWS

Viatris Community Pharmacy Team of the Year Award 2023

Offering Digital Solutions

International furore over pharmacist prescribing proposals

Blood glucose test strips recalled over faulty readings

Quick links

Other info